enVVeno Medical (NVNO) Beginning Cash Balance (2017 - 2018)

enVVeno Medical (NVNO) recorded quarterly Beginning Cash Balance of -$9136.0 in Q2 2018, down 107.03% quarter-over-quarter from $130000.0 in Q1 2018.

enVVeno Medical (NVNO) Beginning Cash Balance (2017 - 2018) Analysis & Trends

enVVeno Medical's Beginning Cash Balance history runs 2 years deep, the most recent figure standing at -$9136.0 for Q2 2018.

In Q2 2018, Beginning Cash Balance changed N/A year-over-year to -$9136.0; the TTM figure through Dec 2018 stood at $120864.0 (changed N/A YoY), while the FY2018 annual figure was $120864.0, down 30.83% from the prior year.
Beginning Cash Balance was -$9136.0 for Q2 2018 at enVVeno Medical, down from $130000.0 in the prior quarter.
In the past five years, Beginning Cash Balance ranged from a high of $130000.0 in Q1 2018 to a low of -$9136.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	enVVeno Medical	6.86 Mn	6.86 Mn	-

Download Data